Fol. Biol. 2005, 51, 3-11
https://doi.org/10.14712/fb2005051010003
Expression of CD44v6 Correlates with Cell Proliferation and Cellular Atypia in Urothelial Carcinoma Cell Lines 5637 and HT1197
Crossref Cited-by Linking
- Aghaalikhani Nazi, Rashtchizadeh Nadereh, Shadpour Pejman, Allameh Abdolamir, Mahmoodi Marzieh: Cancer stem cells as a therapeutic target in bladder cancer. Journal Cellular Physiology 2019, 234, 3197. <https://doi.org/10.1002/jcp.26916>
- Azevedo Rita, Soares Janine, Gaiteiro Cristiana, Peixoto Andreia, Lima Luís, Ferreira Dylan, Relvas-Santos Marta, Fernandes Elisabete, Tavares Ana, Cotton Sofia, Daniel-da-Silva Ana Luísa, Santos Lúcio Lara, Vitorino Rui, Amado Francisco, Ferreira José Alexandre: Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer. Talanta 2018, 184, 347. <https://doi.org/10.1016/j.talanta.2018.03.028>
- Wang Zhe, Zhao Kun, Hackert Thilo, Zöller Margot: CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression. Front. Cell Dev. Biol. 2018, 6. <https://doi.org/10.3389/fcell.2018.00097>
- Weng Wei-Chun, Huang Yu-Hui, Yang Shun-Fa, Wang Shian-Shiang, Kuo Wu-Hsien, Hsueh Chao-Wen, Huang Ching-Hsuan, Chou Ying-Erh: Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan. Tumor Biol. 2016, 37, 6971. <https://doi.org/10.1007/s13277-015-4566-9>
- Mai Kien T., Ball Christopher G., Belanger Eric C.: Noninvasive Papillary Basal-like Urothelial Carcinoma: A Subgroup of Urothelial Carcinomas With Immunohistochemical Features of Basal Urothelial Cells Associated With a High Rate of Recurrence and Progression. Applied Immunohistochemistry & Molecular Morphology 2016, 24, 575. <https://doi.org/10.1097/PAI.0000000000000224>
- Zhao Shujie, Chen Chen, Chang Katherine, Karnad Anand, Jagirdar Jaishree, Kumar Addanki P., Freeman James W.: CD44 Expression Level and Isoform Contributes to Pancreatic Cancer Cell Plasticity, Invasiveness, and Response to Therapy. Clinical Cancer Research 2016, 22, 5592. <https://doi.org/10.1158/1078-0432.CCR-15-3115>
- Fernandes Elisabete, Ferreira José Alexandre, Andreia Peixoto, Luís Lima, Barroso Sérgio, Sarmento Bruno, Santos Lúcio Lara: New trends in guided nanotherapies for digestive cancers: A systematic review. Journal of Controlled Release 2015, 209, 288. <https://doi.org/10.1016/j.jconrel.2015.05.003>
- Ferreira-Teixeira Margarida, Parada Belmiro, Rodrigues-Santos Paulo, Alves Vera, Ramalho José S., Caramelo Francisco, Sousa Vitor, Reis Flávio, Gomes Célia M.: Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors. Oncotarget 2015, 6, 36185. <https://doi.org/10.18632/oncotarget.5517>
- Li Heng, Yu Gan, Shi Runlin, Lang Bin, Chen Xianguo, Xia Ding, Xiao Haibing, Guo Xiaolin, Guan Wei, Ye Zhangqun, Xiao Wei, Xu Hua: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 2014, 13. <https://doi.org/10.1186/1476-4598-13-8>
- van der Horst Geertje, Bos Lieke, van der Pluijm Gabri: Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma. Molecular Cancer Research 2012, 10, 995. <https://doi.org/10.1158/1541-7786.MCR-12-0274>
- Omran Ola M., Ata Hesham S.: CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer. Ultrastructural Pathology 2012, 36, 145. <https://doi.org/10.3109/01913123.2011.651522>
- Langeveld Danielle, Jansen Marnix, Brosens Lodewijk, Morsink Folkert, Offerhaus G. Johan, de Leng Wendy: Diversity Counts. American Journal of Clinical Pathology 2011, 135, 878. <https://doi.org/10.1309/AJCPP3I5HDYWMHJA>
